Skip to content
Baltimore News Journal – Lifestyle
Author:
Indivior Pharmaceuticals Inc.
New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities
March 31, 2026
Indivior Announces Proposed Convertible Senior Notes Offering
March 12, 2026
←
Previous Page
1
2